The Genomics Market refers to the sector of the global economy that focuses on the research, development, manufacturing, and commercialization of products and services related to genomics. Genomics is the study of an organism's entire DNA sequence, including genes and their functions, as well as interactions between genes and the environment. The Genomics Market encompasses a wide range of activities, including DNA sequencing technologies, bioinformatics, genetic testing, personalized medicine, pharmaceutical research and development, agricultural genomics, and more.
The report Genomics Market
is projected to reach USD 83.1 billion by 2028 from USD 46.2 billion in 2023,
at a CAGR of 12.4% during the forecast period of 2023 to 2028.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=613
Genomics Market Dynamics:
Drivers:
- Increasing government
funding to support genomics projects
- Rising incidence and
prevalence of viral diseases and genetic disorders
- Growing incidence of
cancer and increasing applications of next-generation sequencing in cancer
research
- Robust investments in
genomics startups
- Growing applications
of genomics
Trends:
- Partnerships and
collaborations for technological advancements in genomics
- AI in genomics
- Following are the
application of AI in genomics
Opportunities:
- Use of genomics in
specialized/personalized medicine
Challenges:
- Ethical issues
- Dearth of trained
professionals
- Secure storage of
large volumes of sequenced data
Market Segmentation: -
·
Based on product and service,
the genomics market is segmented into consumables and reagents, services, and
instruments, systems, and software. In 2022, the services segment accounted for
the largest share of the genomics market. Genomics services generally include
data quality assessment, comprehensive analysis, interpreting results, and
communicating & presenting results to customers.
·
Based on study type,
the genomics market is segmented into functional genomics, biomarker discovery,
pathway analysis, epigenomics, and other study types. Biomarker discovery
accounted for the second largest share of the genomics market in 2022.
·
Based on application, the market is segmented into drug discovery and development,
diagnostics, agriculture and animal research, and other applications. Drug
discovery and development was the largest application segment in the market in
2022.
·
Based on technology, the market is segmented into sequencing, PCR, microarrays,
flow cytometry, and other technologies. In 2022, the sequencing segment
accounted for the largest share of the market.
Regional Analysis:
The
genomics market is segmented into five major regions: North America, Europe,
Asia Pacific, Latin America, and the Middle East & Africa.
The Europe market is estimated to register the second highest growth during the forecast period. The '1+ Million Genomes' Initiative was introduced in Europe in 2018 to gain access to at least 1 million sequenced genomes in the EU. Since Digital Day 2018, 24 EU countries, the UK, and Norway, have signed member state declarations on inducing efforts toward creating a European data infrastructure for genomic data and implementing the common nation rule to enable federated data access. Such one-of-a-kind initiatives by European countries are expected to propel the growth of the genomics market in this region.
Recent Developments:
- In March 2023,
Illumina, Inc (US) launched Connected Insights, a new cloud-based software
that enables tertiary analysis for clinical next-generation sequencing
data. This software will help the genomic profiling (CGP) for advanced
tumours along with whole-genome sequencing for rare diseases and other
advanced applications.
- In February 2023,
Thermo Fisher Scientific, Inc. (US) launched TrueMark STI Select Panel, a
polymerase chain reaction (PCR) test designed to detect Chlamydia
trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma
genitalium for research applications only.
- In February 2023,
Eppendorf AG (Germany) expanded its production facility in China by
signing a contract for building a new production site in Shanghai.
- In October 2022,
Oxford Nanopore Technologies (UK) collaborated with 10x Genomics (US) to
enable a streamlined workflow for sequencing full-length transcripts in
single reads on highly accessible Oxford Nanopore devices.
Get 10% Free Customization on this
Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=613
Top Key Players:
Key
players in the genomics Market include Illumina, Inc. (US), Thermo Fisher
Scientific, Inc. (US), Danaher Corporation (US), QIAGEN N.V. (Germany), Agilent
Technologies, Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche, Ltd.
(Switzerland),
No comments:
Post a Comment